Anti-MRSA agent 3

This small molecule research compound exhibits potent anti-MRSA activity with a low MIC of 0.098 μg/ml and demonstrates selective cytotoxicity. Its mechanism involves high-affinity binding to bacterial genomic DNA and disruption of cell walls and membranes. This profile supports its utility in in vitro studies of novel antibacterial strategies and resistance mechanisms.